Our lab works to develop novel tailored treatment strategies for pancreatic cancer.

Areas of supervision and new projects include:

1. Validation of new drug targets and developing optimal combination therapies for the treatment of pancreatic cancer
2. Understanding how anti-cancer drug resistance develops. To this end, our lab is applying a combination of whole genome sequencing, single-cell transcriptomics and other molecular analyses to document the emergence of cancer chemoresistance. Our ultimate goal is to refine tailored treatment strategies for pancreatic cancer, overcome or circumvent treatment resistance and build optimal, effective treatment combinations for patients with this disease.